These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 19126653)

  • 1. SNPs in ultraconserved elements and familial breast cancer risk.
    Catucci I; Verderio P; Pizzamiglio S; Manoukian S; Peissel B; Barile M; Tizzoni L; Bernard L; Ravagnani F; Galastri L; Pierotti MA; Radice P; Peterlongo P
    Carcinogenesis; 2009 Mar; 30(3):544-5; author reply 546. PubMed ID: 19126653
    [No Abstract]   [Full Text] [Related]  

  • 2. SNPs in ultraconserved elements and familial breast cancer risk.
    Yang R; Frank B; Hemminki K; Bartram CR; Wappenschmidt B; Sutter C; Kiechle M; Bugert P; Schmutzler RK; Arnold N; Weber BH; Niederacher D; Meindl A; Burwinkel B
    Carcinogenesis; 2008 Feb; 29(2):351-5. PubMed ID: 18174240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymorphisms in BRCA2 resulting in aberrant codon-usage and their analysis on familial breast cancer risk.
    Yang R; Chen B; Hemminki K; Wappenschmidt B; Engel C; Sutter C; Ditsch N; Weber BH; Niederacher D; Arnold N; Meindl A; Bartram CR; Schmutzler RK; Burwinkel B
    Breast Cancer Res Treat; 2009 Nov; 118(2):407-13. PubMed ID: 19229607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A functional promoter polymorphism in the TERT gene does not affect inherited susceptibility to breast cancer.
    Varadi V; Brendle A; Grzybowska E; Johansson R; Enquist K; Butkiewicz D; Pamula-Pilat J; Pekala W; Hemminki K; Lenner P; Försti A
    Cancer Genet Cytogenet; 2009 Apr; 190(2):71-4. PubMed ID: 19380022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetics. DNA test for breast cancer risk draws criticism.
    Couzin J
    Science; 2008 Oct; 322(5900):357. PubMed ID: 18927361
    [No Abstract]   [Full Text] [Related]  

  • 6. Polygenes, risk prediction, and targeted prevention of breast cancer.
    Jernström H
    N Engl J Med; 2008 Sep; 359(13):1407. PubMed ID: 18822457
    [No Abstract]   [Full Text] [Related]  

  • 7. A tiny step closer to personalized risk prediction for breast cancer.
    Devilee P; Rookus MA
    N Engl J Med; 2010 Mar; 362(11):1043-5. PubMed ID: 20237351
    [No Abstract]   [Full Text] [Related]  

  • 8. A novel single nucleotide polymorphism of the cyclooxygenase-2 gene associated with breast cancer.
    Li F; Ren GS; Li HY; Wang XY; Chen L; Li J
    Clin Oncol (R Coll Radiol); 2009 May; 21(4):302-5. PubMed ID: 19138835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FOXP3 germline polymorphisms are not associated with risk of breast cancer.
    Raskin L; Rennert G; Gruber SB
    Cancer Genet Cytogenet; 2009 Apr; 190(1):40-2. PubMed ID: 19264232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ser326Cys polymorphism in DNA repair genes hOGG1 in breast cancer women.
    Romanowicz-Makowska H; Smolarz B; Makowski M; Połać I; Pertyński T
    Pol J Pathol; 2008; 59(4):201-4. PubMed ID: 19391486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fok1 polymorphism of vitamin D receptor gene contributes to breast cancer susceptibility: a meta-analysis.
    Tang C; Chen N; Wu M; Yuan H; Du Y
    Breast Cancer Res Treat; 2009 Sep; 117(2):391-9. PubMed ID: 19145484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mammary tumor development in dogs is associated with BRCA1 and BRCA2.
    Rivera P; Melin M; Biagi T; Fall T; Häggström J; Lindblad-Toh K; von Euler H
    Cancer Res; 2009 Nov; 69(22):8770-4. PubMed ID: 19887619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer genetic risk assessment for individuals at risk of familial breast cancer.
    Guirguis-Blake J
    Am Fam Physician; 2008 Feb; 77(4):449-50. PubMed ID: 18326163
    [No Abstract]   [Full Text] [Related]  

  • 14. Molecular screening of interleukin-6 gene promoter and influence of -174G/C polymorphism on breast cancer.
    Chérel M; Campion L; Bézieau S; Campone M; Charrier J; Gaschet J; Ricolleau G; Gouraud W; Charbonnel C; Jézéquel P
    Cytokine; 2009 Sep; 47(3):214-23. PubMed ID: 19640729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of genetic polymorphisms of EXO1 gene with risk of breast cancer in Taiwan.
    Wang HC; Chiu CF; Tsai RY; Kuo YS; Chen HS; Wang RF; Tsai CW; Chang CH; Lin CC; Bau DT
    Anticancer Res; 2009 Oct; 29(10):3897-901. PubMed ID: 19846925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic variation in IGF-1 and breast cancer risk in Ashkenazi carriers and noncarriers of BRCA1/2 mutations.
    Khoury-Shakour S; Lejbkowicz F; Barnett-Griness O; Tamir A; Pinchev M; Rennert G
    Eur J Cancer Prev; 2009 Sep; 18(5):361-7. PubMed ID: 19543094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chromosome copy number variation and breast cancer risk.
    Tchatchou S; Burwinkel B
    Cytogenet Genome Res; 2008; 123(1-4):183-7. PubMed ID: 19287154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Relationship between mutation of BRCA1 and susceptibility to early onset of breast cancer].
    Meng J; Shi YR; Niu RF; Fu L
    Zhonghua Yi Xue Za Zhi; 2009 Jan; 89(2):79-82. PubMed ID: 19489266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Germline mutations in CDKN2A are infrequent in female patients with melanoma and breast cancer.
    Nagore E; Montoro A; García-Casado Z; Botella-Estrada R; Insa A; Lluch A; López-Guerrero JA; Guillén C
    Melanoma Res; 2009 Aug; 19(4):211-4. PubMed ID: 19571771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update on genetic predisposition to breast cancer.
    Ahmed M; Lalloo F; Evans DG
    Expert Rev Anticancer Ther; 2009 Aug; 9(8):1103-13. PubMed ID: 19671030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.